CDC42-dependent autophagy regulates the hematopoietic niche
Oncology Research and Treatment
2020
43 Suppl 4
SUPPL 4
86-86
BONE MARROW TRANSPLANTATION COMPROMISES THE REGENERATIVE CAPACITY OF THE BONE MARROW NICHE
Exp Hematol
2020
88 Suppl S
S49-S49
Microenvironmental SFRP1 controls repopulating activity of Hematopoietic Stem Cells via PP2A-mediated regulation of CTNNB1/EP300
Oncology Research and Treatment
2020
43 Suppl 4
SUPPL 4
32-33
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial.
Blood
2020
136
26
3041-3050
Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in Patients With Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Phase 1 and Randomized Phase 2 Trial.
JAMA Oncol
2020
6
8
1203-1209
Casein kinase 1.2 over expression restores stress resistance to Leishmania donovani HSP23 null mutants.
Sci Rep
2020
10
1
Authentication of Primary Murine Cell Lines by a Microfluidics-Based Lab-On-Chip System.
Biomedicines
2020
8
12
Molecular Subgroups of T Cell Acute Lymphoblastic Leukemia in Adults Treated According to GMALL Protocols
Blood
2020
136 Suppl 1
Three versus one year of adjuvant imatinib for high-risk gastrointestinal stromal tumor (GIST): Survival analysis of a randomized trial after 10 years of follow-up.
J Clin Oncol
2020
38 Suppl S
15
Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms.
Nature
2020
588
7836
157-163